Get App
Download App Scanner
Scan to Download
Advertisement

Marksans Pharma Q4: Topline Rises 21%, Net Profit Up 63% YoY

Marksans Pharma Q4: Topline Rises 21%, Net Profit Up 63% YoY

Read Time: 1 min
Add NDTV Profit As Google Preferred Source
Share
Marksans Pharma Q4: Topline Rises 21%, Net Profit Up 63% YoY

Marksans Pharma Q4: Topline Rises 21%, Net Profit Up 63% YoY

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email
Newsletter Preview

Videos

Watch
LIVE

News for You

Mutual Funds Are Cutting Exit Loads — What Does It Mean, And Should Investors Care?

Mutual Funds Are Cutting Exit Loads — What Does It Mean, And Should Investors Care?

Live TV
Apps
Social
Hello Reader
Sign In / Register
Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source